Piroxicam

吡罗昔康

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NamePiroxicam
Drug Alias Namepiroxicamum吡罗昔康Feldene FastFeldeneFelden +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsAnkle InjuriesRenal ColicLow Back Pain +[14] 
Global Approved IndicationsLow Back PainPainPeriarthritis +[7] 
Approved Indications in ChinaPainArthritis
Original Approved Country/TerritoryCanada
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTunisia +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPt Taisho Pharmaceutical Indonesia TbkUniversity Of MonastirPfizer Inc +[7] 
Inactive CompaniesNanoform Finland PLCPfizer Canada UlcArdabil University Of Medical Sciences
Active IndicationsAnkle InjuriesRenal ColicLow Back Pain +[14] 
Inactive IndicationsN/A

Other Information

ATC CodeM01AC01M02AA07S01BC06
Related LinksWikipediaDrugBankKEGG